background clinical mood disorders often become clinically manifest in the later teenage years and early twenties and can be associated with a poor longterm prognosisthe primary prevention of these disorders would therefore have great public health valuenutritional supplements are a feasible intervention for primary prevention and several epidemiological studies have indicated links between low folate status and depressive symptomatology in the general populationmethod a randomised double blind parallel group placebocontrolled trial in which participants aged 1424 years at increased familial risk of mood disorder were randomised to folic acid 25 mg daily or identical placebo liquid for a maximum of 36 monthsprimary outcome data the onset of a dsmiv mood disorder were collected from 112 participants 56 per groupresults the incidence of mood disorder in the folic acid and placebo groups were 143 and 179 respectively a nonsignificant differencehowever there was posthoc evidence that folic acid delayed the time to onset of mood disorder in those participants who became unwelllimitations small sample size and rate of onset of mood disorders lower than expectedconclusions although long term folic acid supplementation was well tolerated with high levels of adherence there was no evidence that it reduced the incidence of mood disorder compared to those taking placebocopyright  2014 elsevier bv all rights reserved